Literature DB >> 14769027

19F NMR studies of plasminogen activator inhibitor-1.

Glenn L Abbott1, Grant E Blouse, Michel J Perron, Joseph D Shore, Linda A Luck, Arthur G Szabo.   

Abstract

Plasminogen activator inhibitor-1 (PAI-1) is a 43 kDa protein involved in the regulation of fibrinolysis. PAI-1 is the principal inhibitor of tissue-type plasminogen activator (t-PA), trapping the proteinase as an acyl-enzyme covalent complex (approximately 105 kDa). Four single tryptophan mutants of PAI-1 have been constructed in which three of the four tryptophan residues (Trp86, Trp139, Trp175, and Trp262) were replaced with phenylalanine. Biosynthetic incorporation of 5-fluorotryptophan (5F-Trp) into wild-type PAI-1 (5FW wtPAI-1) and the single tryptophan mutants (5FW86, 5FW139, 5FW175, and 5FW262) was achieved, allowing a (19)F NMR spectroscopic study of PAI-1 in its active and cleaved forms and in complex with t-PA. The (19)F NMR spectrum of active 5FW wtPAI-1 shows four clearly resolved peaks at -39.20, -49.26, -50.74, and -52.57 ppm relative to trifluoroacetic acid at 0 ppm. Unequivocal assignments of these four resonances in the spectrum of 5FW wtPAI-1 to specific tryptophan residues were accomplished by measuring the chemical shifts of the (19)F resonances of the single tryptophan mutants. There was close agreement between the resonances observed in 5FW wtPAI-1 and of those in the mutants for all three protein forms. This would imply little structural perturbation in the local structures of the tryptophan residues resulting from substitution by phenylalanine. The 5FW wtPAI-1 was observed to have lower second-order rate constant (k(app)) for the inhibition of t-PA than the natural tryptophan wtPAI-1, suggesting that the decreased activity may result from a small structural effect of the fluorine substituent of the indole ring. Further alterations in the k(app) and the stoichiometry of inhibition (SI) were observed in each of the mutants indicating an effect of the three tryptophan to phenylalanine mutations. Detailed interpretation of the (19)F NMR spectra of the PAI-1 mutants provides insights into the local segmental structure of the active form of the proteins and the structural changes that occur in the cleaved and t-PA complexed forms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14769027     DOI: 10.1021/bi035618a

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Quantitation of protein expression in a cell-free system: Efficient detection of yields and 19F NMR to identify folded protein.

Authors:  Muniasamy Neerathilingam; Lesley H Greene; Simon A Colebrooke; Iain D Campbell; David Staunton
Journal:  J Biomol NMR       Date:  2005-01       Impact factor: 2.835

2.  Effects of Phe-to-Trp mutation and fluorotryptophan incorporation on the solution structure of cardiac troponin C, and analysis of its suitability as a potential probe for in situ NMR studies.

Authors:  Xu Wang; Pascal Mercier; Paul-Jean Letourneau; Brian D Sykes
Journal:  Protein Sci       Date:  2005-09       Impact factor: 6.725

3.  Domain swapping proceeds via complete unfolding: a 19F- and 1H-NMR study of the Cyanovirin-N protein.

Authors:  Lin Liu; In-Ja L Byeon; Ivet Bahar; Angela M Gronenborn
Journal:  J Am Chem Soc       Date:  2012-02-22       Impact factor: 15.419

4.  Efficient syntheses of 5'-deoxy-5'-fluoroguanosine and -inosine.

Authors:  Robert C Spitale; Moriah G Heller; Amanda J Pelly; Joseph E Wedekind
Journal:  J Org Chem       Date:  2007-09-29       Impact factor: 4.354

Review 5.  Can components of the plasminogen activation system predict the outcome of kidney transplants?

Authors:  Jerzy Jankun; Omar A Khan; Hesham I Mostafa; Puneet Sindhwani; Ewa Skrzypczak-Jankun
Journal:  Cent Eur J Immunol       Date:  2018-06-30       Impact factor: 2.085

6.  Fluorotryptophan Incorporation Modulates the Structure and Stability of Transthyretin in a Site-Specific Manner.

Authors:  Xun Sun; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2017-09-28       Impact factor: 3.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.